| Metric | შპს სანდო ფარმა | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾1.3m₾4.9m | ₾2.11bn₾1.93bn |
| Revenue growth | -72.8% | 9.5% |
| Profitability | ||
| EBITDA | -₾369k-₾103k | — |
| EBITDA margin | -27.5%-2.1% | — |
| Net profit | -₾369k-₾103k | ₾1.12bn₾1.02bn |
| Net margin | -27.5%-2.1% | 53.0%53.1% |
| Balance sheet | ||
| Total assets | ₾684k₾702k | ₾31.77bn₾28.33bn |
| Total equity | -₾157k₾212k | ₾4.75bn₾4.27bn |
| ROE | —-48.4% | 23.6%24.0% |